Publications by authors named "Andrea Perrone"

Claim this Profile
V
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric study.
Massimiliano Postorino, Renato Massoud, Luca Guarnera, Elisa Meddi, Giorgio Vacros, Andrea Perrone

Panminerva Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Reduced Physical Activity on the Lipid Profile in Patients with High Cardiovascular Risk during COVID-19 Lockdown.
Marco Alfonso Perrone, Alessandro Feola, Massimo Pieri, Bruno Donatucci, Chiara Salimei, Andrea Perrone

Int J Environ Res Public Health· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Diesse Cube 30 touch erythrocyte sedimentation method in comparison with Alifax test 1 and the manual Westergren gold standard method.
Massimo Pieri, Stefano Pignalosa, Marco Alfonso Perrone, Carmelo Russo, Gianluca Noce, Andrea Perrone

Scand J Clin Lab Invest· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST.
Gregory V Goldmacher, Anuradha D Khilnani, Robert H I Andtbacka, Jason J Luke, F Stephen Hodi, Andrea Perrone

J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Poly (Vinylidene Fluoride) (PVDF) Electrospun Nanofiber Membrane Preparation Using DMSO as a Low Toxicity Solvent.
Francesca Russo, Claudia Ursino, Elisa Avruscio, Giovanni Desiderio, Andrea Perrone

Membranes (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Richard W Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, Wen-Jen Hwu, Jedd D Wolchok, Andrea Perrone

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.
Richard W Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, Wen-Jen Hwu, Jedd D Wolchok, Andrea Perrone

Clin Cancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Lesley Seymour, Jan Bogaerts, Andrea Perrone, Robert Ford, Lawrence H Schwartz

Lancet Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.
F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jeffrey S Weber, Adil Daud, Andrea Perrone

J Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer.
P David Mozley, Claus Bendtsen, Binsheng Zhao, Lawrence H Schwartz, Matthias Thorn, Andrea Perrone

Transl Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity.
Sergio Valente, Maria Tardugno, Mariarosaria Conte, Roberto Cirilli, Andrea Perrone

ChemMedChem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging technologies and translational medicine.
Andrea Perrone

J Nucl Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.
Antonello Mai, Donghang Cheng, Mark T Bedford, Sergio Valente, Angela Nebbioso, Andrea Perrone

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: histone deacetylase inhibition and in-cell activities.
Antonello Mai, Andrea Perrone, Angela Nebbioso, Dante Rotili, Sergio Valente

Bioorg Med Chem Lett· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.
Aaron B Kantor, Jun Deng, Emmanuelle Waubant, Hua Lin, Christopher H Becker, Andrea M Perrone

J Neuroimmunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors.
Antonello Mai, Sergio Valente, Donghang Cheng, Andrea Perrone, Rino Ragno

ChemMedChem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker discovery by comprehensive phenotyping for autoimmune diseases.
Aaron B Kantor, Weixun Wang, Hua Lin, Harini Govindarajan, Markus Anderle, Andrea Perrone

Clin Immunol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis